Shokufeh Tavassoli1, Gayathri Nayar2, Kieren Darcy3, Mariusz Grzeda3, Jon Luck4, O Martin Williams2, Derek Tole3. 1. Bristol Eye Hospital, Cornea and Refractive Surgery, Bristol, United Kingdom. shokufeh_tavassoli@hotmail.com. 2. University Hospitals Bristol and Public Health England Microbiology Laboratory Services Bristol, Bristol, United Kingdom. 3. Bristol Eye Hospital, Cornea and Refractive Surgery, Bristol, United Kingdom. 4. Royal United Hospital Bath, Bristol, United Kingdom.
Abstract
BACKGROUND: The aims of this study were to identify the organisms responsible for microbial keratitis, as identified by corneal scrape using brain-heart infusion broth, trends over time and antimicrobial sensitivities, over an 11-year period at two eye units in the South West of England; Bristol Eye Hospital and Royal United Hospital, Bath. METHODS: All corneal scrapes performed and sent for microbiological analysis between 4th April 2006 and 31st October 2017 at the two eye units were retrospectively reviewed. First-line treatment was monotherapy with levofloxacin 0.5% and second-line treatment was a combination of cefuroxime 5% and gentamicin 1.5%. Both direct and enrichment cultures were used. RESULTS: In total, 2614 corneal scrapes from 2116 patients (1082 female, mean age 47.7 ± 21.2 years) were identified. 38.1% (n = 996) were culture positive and 1195 organisms were cultured. In all, 91.6% were bacteria (69.4% were gram-positive, 30.6% gram-negative). Coagulase-negative Staphylococci (CoNS) were the most commonly cultured organism (n = 430). Pseudomonas aeruginosa was the most commonly identified gram-negative organism (n = 189). In total, 6.9% (n = 83) of organisms cultured were fungi. In all, 1.4% (n = 17) were acanthamoeba. There was no statistically significant trend in the organisms observed over the study period. Sensitivity testing confirmed reasonable sensitivity to the empiric antibiotics used in clinical practice. CONCLUSIONS: This is the first report on microbial keratitis trends in the South West of England. Virulent organisms were likely to be detected on direct culture, whereas low virulent organisms such as CoNS were more likely to be detected on enrichment alone. Antibiotic sensitivity testing confirmed fluoroquinolone monotherapy as appropriate first-line treatment.
BACKGROUND: The aims of this study were to identify the organisms responsible for microbial keratitis, as identified by corneal scrape using brain-heart infusion broth, trends over time and antimicrobial sensitivities, over an 11-year period at two eye units in the South West of England; Bristol Eye Hospital and Royal United Hospital, Bath. METHODS: All corneal scrapes performed and sent for microbiological analysis between 4th April 2006 and 31st October 2017 at the two eye units were retrospectively reviewed. First-line treatment was monotherapy with levofloxacin 0.5% and second-line treatment was a combination of cefuroxime 5% and gentamicin 1.5%. Both direct and enrichment cultures were used. RESULTS: In total, 2614 corneal scrapes from 2116 patients (1082 female, mean age 47.7 ± 21.2 years) were identified. 38.1% (n = 996) were culture positive and 1195 organisms were cultured. In all, 91.6% were bacteria (69.4% were gram-positive, 30.6% gram-negative). Coagulase-negative Staphylococci (CoNS) were the most commonly cultured organism (n = 430). Pseudomonas aeruginosa was the most commonly identified gram-negative organism (n = 189). In total, 6.9% (n = 83) of organisms cultured were fungi. In all, 1.4% (n = 17) were acanthamoeba. There was no statistically significant trend in the organisms observed over the study period. Sensitivity testing confirmed reasonable sensitivity to the empiric antibiotics used in clinical practice. CONCLUSIONS: This is the first report on microbial keratitis trends in the South West of England. Virulent organisms were likely to be detected on direct culture, whereas low virulent organisms such as CoNS were more likely to be detected on enrichment alone. Antibiotic sensitivity testing confirmed fluoroquinolone monotherapy as appropriate first-line treatment.
Authors: Rose Herbert; Mary Caddick; Tobi Somerville; Keri McLean; Shakeel Herwitker; Timothy Neal; Gabriela Czanner; Stephen Tuft; Stephen B Kaye Journal: BMJ Open Ophthalmol Date: 2022-07
Authors: Darren Shu Jeng Ting; Jessica Cairns; Bhavesh P Gopal; Charlotte Shan Ho; Lazar Krstic; Ahmad Elsahn; Michelle Lister; Dalia G Said; Harminder S Dua Journal: Front Med (Lausanne) Date: 2021-08-11
Authors: Darren Shu Jeng Ting; Charlotte Shan Ho; Rashmi Deshmukh; Dalia G Said; Harminder S Dua Journal: Eye (Lond) Date: 2021-01-07 Impact factor: 3.775
Authors: Darren Shu Jeng Ting; Charlotte Shan Ho; Jessica Cairns; Ahmad Elsahn; Mouhamed Al-Aqaba; Tim Boswell; Dalia G Said; Harminder Singh Dua Journal: Br J Ophthalmol Date: 2020-06-24 Impact factor: 4.638
Authors: Darren Shu Jeng Ting; Mohamed Galal; Bina Kulkarni; Mohamed S Elalfy; Damian Lake; Samer Hamada; Dalia G Said; Harminder S Dua Journal: J Fungi (Basel) Date: 2021-11-12
Authors: Darren S J Ting; Bhavesh P Gopal; Rashmi Deshmukh; Gerami D Seitzman; Dalia G Said; Harminder S Dua Journal: Ocul Surf Date: 2021-11-13 Impact factor: 5.033
Authors: Imran Mohammed; Harminder S Dua; Darren Shu Jeng Ting; Eunice Tze Leng Goh; Venkatesh Mayandi; Joanna M F Busoy; Thet Tun Aung; Mercy Halleluyah Periayah; Mario Nubile; Leonardo Mastropasqua; Dalia G Said; Hla M Htoon; Veluchamy Amutha Barathi; Roger W Beuerman; Rajamani Lakshminarayanan Journal: Sci Rep Date: 2021-09-15 Impact factor: 4.379